Eli Lilly Leads Biopharma in New Ranking

Eli Lilly holds the top spot in a new industry ranking. The company moved up from 16th place in just five years. This ranking looks at development, access, and sales for new medicines.

Lilly's success comes from its strong pipeline and popular drugs. These medicines include treatments for diabetes and weight loss. The company develops these drugs quickly and gets them to patients.

Norstella created this new index. It looked at 25 large, global biopharma companies. Eli Lilly's ability to launch successful drugs helped it reach number one. This shows how well the company turns new ideas into real treatments for people.

Source: FierceBiotech